上周,强生公司在公布第三季度财报时宣布了一个更重磅的消息,计划在未来18至24个月内,将骨科业务分拆为一家名为DePuy Synthes的独立公司。今年以来,已有多家全球知名医疗巨头宣布了业务拆分计划,旨在通过聚焦核心业务应对市场变化,提升竞争力。在这一背景下,骨科行业正迎来一轮大洗牌,下一个“巨无霸”也有望诞生,加剧与目前市场主要参与者史赛克、捷迈邦美的正面竞争。最新拆分的强生骨科年收入近...
Source Link上周,强生公司在公布第三季度财报时宣布了一个更重磅的消息,计划在未来18至24个月内,将骨科业务分拆为一家名为DePuy Synthes的独立公司。今年以来,已有多家全球知名医疗巨头宣布了业务拆分计划,旨在通过聚焦核心业务应对市场变化,提升竞争力。在这一背景下,骨科行业正迎来一轮大洗牌,下一个“巨无霸”也有望诞生,加剧与目前市场主要参与者史赛克、捷迈邦美的正面竞争。最新拆分的强生骨科年收入近...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.